{
    "organizations": [],
    "uuid": "95543eb9fbff30f666f1128344a81d2d45ab39c2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-intec-pharma-announces-pricing-of/brief-intec-pharma-announces-pricing-of-35-4-mln-public-offering-of-ordinary-shares-idUSASC09VJR",
    "ord_in_thread": 0,
    "title": "BRIEF-Intec Pharma Announces Pricing Of $35.4 Mln Public Offering Of Ordinary Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11, 2018 / 1:02 PM / Updated 17 minutes ago BRIEF-Intec Pharma Announces Pricing Of $35.4 Mln Public Offering Of Ordinary Shares Reuters Staff \nApril 11 (Reuters) - Intec Pharma Ltd: \n* INTEC PHARMA ANNOUNCES PRICING OF $35.4 MILLION PUBLIC OFFERING OF ORDINARY SHARES \n* PRICED UNDERWRITTEN PUBLIC OFFERING OF 6.75 MILLION OF ITS ORDINARY SHARES AT A PUBLIC OFFERING PRICE OF $5.25 PER ORDINARY SHARE Source text for Eikon: Further company coverage:",
    "published": "2018-04-11T16:02:00.000+03:00",
    "crawled": "2018-04-11T16:26:31.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "announces",
        "pricing",
        "mln",
        "public",
        "offering",
        "ordinary",
        "share",
        "reuters",
        "staff",
        "april",
        "reuters",
        "intec",
        "pharma",
        "ltd",
        "intec",
        "pharma",
        "announces",
        "pricing",
        "million",
        "public",
        "offering",
        "ordinary",
        "share",
        "priced",
        "underwritten",
        "public",
        "offering",
        "million",
        "ordinary",
        "share",
        "public",
        "offering",
        "price",
        "per",
        "ordinary",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}